44 results on '"Luo, Jian-Quan"'
Search Results
2. Three-dimensional numerical study of flow characteristic and membrane fouling evolution in an enzymatic membrane reactor
3. Comparison of the effectiveness of probiotic supplementation in glucose metabolism, lipid profile, inflammation and oxidative stress in pregnant women
4. Blood group antigen A carriers exhibit an extended progression‐free survival with no more immune‐related adverse events
5. Editorial: Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
6. Systematic Mendelian randomization study of the effect of gut microbiome and plasma metabolome on severe COVID-19
7. The human glucose and lipid homeostasis–associated genetic polymorphisms do not regulate SLC25A47 gene expression in the liver
8. Blood Group Antigen A Carriers Exhibit an Extended Progression‐Free Survival with no more Immune‐Related Adverse Events.
9. Drug-induced hyperglycaemia and diabetes: pharmacogenomics perspectives
10. Multidimensional evaluation of teaching strategies for pharmacology based on a comprehensive analysis involving 21,269 students
11. Pharmacogenomics and Pharmacomicrobiomics in Type 2 Diabetes Mellitus (T2DM)
12. European versus Asian differences for the associations between paraoxonase‐1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus
13. Magnesium Isoglycyrrhizinate Attenuates Anti-Tuberculosis Drug-Induced Liver Injury by Enhancing Intestinal Barrier Function and Inhibiting the LPS/TLRs/NF-κB Signaling Pathway in Mice
14. Comparative effectiveness of glycyrrhizic acid preparations aimed at preventing and treating anti-tuberculosis drug-induced liver injury: A network meta-analysis of 97 randomized controlled trials
15. Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment
16. WNT3A rs752107(C > T) Polymorphism Is Associated With an Increased Risk of Essential Hypertension and Related Cardiovascular Diseases
17. Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatment
18. Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities
19. Genetic association of hypoxia inducible factor 1-alpha (HIF1A) Pro582Ser polymorphism with risk of diabetes and diabetic complications
20. Evaluating the role of GSTP1 genetic polymorphism (rs1695, 313A>G) as a predictor in cyclophosphamide-induced toxicities.
21. Clinical Factors and Rate of Cough During Angiotensin‐Converting Enzyme Inhibitor Treatment
22. Three-dimensional numerical study of flow characteristics and membrane fouling evolution in an enzymatic membrane reactor
23. Association of PON2 Gene Polymorphisms (Ser311Cys and Ala148Gly) With the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Population
24. Diclofenac--Acetaminophen Combination Induced Acute Kidney Injury In Postoperative Pain Relief
25. EuropeanversusAsian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus
26. WITHDRAWN: The platelet membrane glycoprotein VI genetic polymorphism (rs1613662, 13254T>C) is not associated with the risk of coronary artery disease
27. The Associations between Apolipoprotein E Gene Epsilon2/Epsilon3/Epsilon4 Polymorphisms and the Risk of Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus
28. Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients
29. Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis
30. IL-3 and CTLA4 gene polymorphisms may influence the tacrolimus dose requirement in Chinese kidney transplant recipients
31. Pharmacogenomics and Herb-Drug Interactions: Merge of Future and Tradition
32. Association between GNB3 c.825C > T polymorphism and the risk of overweight and obesity: A meta-analysis
33. Clinical use of azelnidipine in the treatment of hypertension in Chinese patients
34. European <italic>versus</italic> Asian differences for the associations between paraoxonase‐1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus.
35. SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril) -Induced Cough: a Pharmacogenetic Study
36. SLCO1B1 variants and enalapril-induced cough: a pharmacogenetics study in China
37. Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertension
38. Endothelial Nitric Oxide Synthase Gene G894T Polymorphism and Myocardial Infarction: A Meta-Analysis of 34 Studies Involving 21068 Subjects
39. Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan
40. Clinical use of azelnidipine in the treatment of hypertension in Chinese patients.
41. Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan.
42. Rs495828 polymorphism of the ABOgene is a predictor of enalapril-induced cough in Chinese patients with essential hypertension
43. Clinical Factors and Rate of Cough During Angiotensin‐Converting Enzyme Inhibitor Treatment.
44. SLCO1B1variants and enalapril-induced cough: a pharmacogenetics study in China
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.